# Evaluating the potential of acupuncture for Alzheimer’s disease treatment: A meta-analysis and systematic review of mouse model studies

**Authors:** Mohan Yang, Liqi Tong, Zhiling Guo, Zhiqun Tan, Todd C. Holmes, Zhaoxia Yu, Xiangmin Xu

PMC · DOI: 10.1038/s41398-026-03923-9 · 2026-03-17

## TL;DR

This paper reviews mouse studies to evaluate how acupuncture, specifically electroacupuncture, affects Alzheimer’s disease pathology and cognitive function.

## Contribution

The study provides a meta-analysis and systematic review of electroacupuncture effects on Alzheimer’s disease in mouse models.

## Key findings

- Electroacupuncture reduces amyloid-beta and phosphorylated tau levels in AD mouse models.
- EA decreases neuroinflammatory biomarkers like activated microglia and astrocytes.
- EA improves cognitive functions in Alzheimer’s disease mouse models.

## Abstract

Acupuncture is an ancient practice that was developed within the framework of traditional Chinese medicine. While acupuncture has been recently proposed as a therapy for Alzheimer’s disease (AD), acupuncture effects are not well understood in terms of neural mechanisms. Here, we review and examine the studies that used AD mouse models and analyze the experiments where researchers administered electroacupuncture (EA) to AD mice to assess the potential therapeutic impact of acupuncture on disease pathology and cognitive function in controlled laboratory settings. We analyzed 29 relevant PubMed articles published between January 2014 and July 2025. Our results reveal that EA significantly reduces both amyloid-beta (Aβ) and phosphorylated tau (p-tau) levels and neuroinflammatory biomarkers, including molecular signatures for activated microglia and astrocytes in the brain. EA also enhances cognitive functions. While no study directly compared acupoint strategies, the indirect comparisons in our network analysis suggest that GV20 has potential as a therapeutic target for AD. Our present meta-analysis and review of literature add to the evidence of integrative health practices for acupuncture-based Alzheimer’s disease treatment.

## Linked entities

- **Diseases:** Alzheimer’s disease (MONDO:0004975)
- **Species:** Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** Iba1 (induction of brown adipocytes 1) [NCBI Gene 114737], Gfap (glial fibrillary acidic protein) [NCBI Gene 14580], App (amyloid beta precursor protein) [NCBI Gene 11820] {aka Abeta, Abpp, Adap, Ag, Cvap, E030013M08Rik}, Il1b (interleukin 1 beta) [NCBI Gene 16176] {aka IL-1beta, Il-1b}, Tnfrsf8 (tumor necrosis factor receptor superfamily, member 8) [NCBI Gene 21941] {aka Cd30, D1S166E, Ki, Ki-1}, APP (amyloid beta precursor protein) [NCBI Gene 351] {aka AAA, ABETA, ABPP, AD1, APPI, CTFgamma}, IL1B (interleukin 1 beta) [NCBI Gene 3553] {aka IL-1, IL1-BETA, IL1F2, IL1beta}, Psen1 (presenilin 1) [NCBI Gene 19164] {aka Ad3h, PS-1, PS1, S182}, GFAP (glial fibrillary acidic protein) [NCBI Gene 2670] {aka ALXDRD}
- **Diseases:** neurodegeneration (MESH:D019636), neuroinflammation (MESH:D000090862), cognitive decline (MESH:D003072), pain (MESH:D010146), brain injury (MESH:D001930), neurofibrillary tangle (MESH:D055956), Inflammatory (MESH:D007249), memory loss (MESH:D008569), AD (MESH:D000544), amyloid (MESH:C000718787), dementia (MESH:D003704)
- **Chemicals:** GB13 (-)
- **Species:** Homo sapiens (human, species) [taxon 9606], Mus musculus (house mouse, species) [taxon 10090], Rattus norvegicus (brown rat, species) [taxon 10116]

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC13002870/full.md

---
Source: https://tomesphere.com/paper/PMC13002870